{"transactions":[{"id":4614438,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":107961,"kind":"person","name":"Dash Barry H","position":1,"cik":"0001324222","reported_name":"Dash Barry H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-10T17:29:27.000Z","date":"2026-08-19","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":0.287,"value":8610.0,"ownership":{"direct":true},"balance_after":3265555,"source":{"system":"sec-edgar","filing":"0001324222-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1324222/000132422226000001/primary_doc.xml","form_type":"4"}},{"id":1729765,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":107961,"kind":"person","name":"Dash Barry H","position":1,"cik":"0001324222","reported_name":"Dash Barry H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-27T23:50:54.000Z","date":"2023-11-22","kind":"grant","planned":false,"acquired":true,"shares":547657,"price":0.0365,"value":19989.4805,"ownership":{"direct":true},"balance_after":3235555,"source":{"system":"sec-edgar","filing":"0001324222-23-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000132422223000001/primary_doc.xml","form_type":"4"}},{"id":2172139,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":107961,"kind":"person","name":"Dash Barry H","position":1,"cik":"0001324222","reported_name":"Dash Barry H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-29T17:35:48.000Z","date":"2022-08-28","kind":"grant","acquired":true,"shares":459536,"price":0.0435,"value":19989.816,"ownership":{"direct":true},"balance_after":2687898,"source":{"system":"sec-edgar","filing":"0001324222-22-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000132422222000001/primary_doc.xml","form_type":"4"}},{"id":2648357,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":107961,"kind":"person","name":"Dash Barry H","position":1,"cik":"0001324222","reported_name":"Dash Barry H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-01T22:20:57.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":295570,"price":0.0677,"value":20010.089,"ownership":{"direct":true},"balance_after":2228182,"source":{"system":"sec-edgar","filing":"0001324222-21-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000132422221000001/primary_doc.xml","form_type":"4"}},{"id":3048988,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":107961,"kind":"person","name":"Dash Barry H","position":1,"cik":"0001324222","reported_name":"Dash Barry H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-24T18:11:18.000Z","date":"2020-08-20","kind":"grant","acquired":true,"shares":516781,"price":0.0871,"value":45011.6251,"ownership":{"direct":true},"balance_after":1932612,"source":{"system":"sec-edgar","filing":"0001324222-20-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000132422220000002/primary_doc.xml","form_type":"4"}},{"id":4031105,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":107961,"kind":"person","name":"Dash Barry H","position":1,"cik":"0001324222","reported_name":"Dash Barry H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-02-27T21:42:39.000Z","date":"2018-02-26","kind":"grant","acquired":true,"shares":161374,"price":0.1239,"value":19994.2386,"ownership":{"direct":true},"balance_after":1415831,"source":{"system":"sec-edgar","filing":"0001053369-18-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000105336918000002/primary_doc.xml","form_type":"4"}},{"id":4422223,"issuer":{"id":5936,"kind":"organization","name":"ELITE PHARMACEUTICALS INC /NV/","symbol":"ELTP"},"owners":[{"id":107961,"kind":"person","name":"Dash Barry H","position":1,"cik":"0001324222","reported_name":"Dash Barry H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-27T23:17:47.000Z","date":"2017-02-23","kind":"grant","acquired":true,"shares":88679,"price":0.2255,"value":19997.1145,"ownership":{"direct":true},"balance_after":1254457,"source":{"system":"sec-edgar","filing":"0001053369-17-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053369/000105336917000002/primary_doc.xml","form_type":"4"}}]}